VasQ
Laminate Medical Technologies · Decision date Oct 29, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for K263598, trade name VasQ, on October 29, 2026, with the submission received September 30, 2026. The applicant is Laminate Medical Technologies of Tel Aviv, Israel; the regulation is 21 CFR 870.4600, Class II, product code QVQ, and the review panel and medical specialty are Cardiovascular. SESE is a 510(k) clearance, not a premarket approval.
The summary describes VasQ as a nitinol extravascular support implanted over an end-to-side upper extremity arteriovenous fistula anastomosis, supplied in five models covering artery and vein diameters of 2 mm to 6 mm. The change from the predicate VasQ (DEN220026, K240119) is removal of the smallest model, model 1, with corresponding revision of the model selection tool and implantation chart and minor labeling updates. The summary states no new performance testing was performed and prior testing was relied on; no independent clinical outcome data appear in the provided documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 29, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263598
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Laminate Medical Technologies
- Product code
- QVQ
- Decision code
- SESE
- Decision date
- Oct 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Extravascular Support For An Arteriovenous Fistula For Vascular Access.
- Applicant
- Laminate Medical Technologies
- Product code
- QVQ
- FDA device class
- 2
FDA decision timeline
K263598 received
Application receipt date recorded by FDA.
K263598 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Laminate Medical Technologies
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Tel Aviv
Sources and methodology
- Original FDA record: K263598
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records